FDA Expands Clearance of Ipsogen JAK2 Assay for Myeloproliferative Neoplasms

A diagnostic test previously FDA-approved to detect the JAK2 gene in patients suspected of having polycythemia vera is now approved for use in essential thrombocythemia and primary myelofibrosis.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.